It is a pharma private limited company based in Mumbai, Maharashtra, India, established in 2005.
2005 | Mumbai, Maharashtra, India | ActiveEuphoria Formulation Private Limited, a active private limited company, was established on 16 June 2005 in Mumbai, Maharashtra, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U51397MH2005PTC154012. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹2.00 M and a paid-up capital of ₹0.50 M.
It upholds a compliant status. Its leadership includes Nikhil Jain (Director), Mishrimal Valchand Jain (Director). Past directors included Bhavesh Jayantilal Shah, Chirag Jain, Nikhil Jain. It holds ₹2.07 Cr open charges and ₹2.00 M settled loans. Its latest AGM occurred on 26 September 2025, with the balance sheet filed on 31 March 2025. It is based at 1/12,Varma Nagar, Old Nagardas Road, Andheri East,, Mumbai, Maharashtra, 400069.
U51397MH2005PTC154012
154012
16 June 2005
₹2.00 M
₹0.50 M
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Euphoria Formulation Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Nikhil Jain | Director | 21 Jun 2011 | Current |
| Mishrimal Valchand Jain | Director | 08 Sep 2009 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 01 Jun 2010 | Past |
| Pramod Abcsdd | Director | 23 Jun 2011 | Past |
| Pramod Abcsdd | Additional Director | 29 Sep 2016 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Euphoria Formulation Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 3.37% increase. The company also saw a substantial improvement in profitability, with a 19.05% increase in profit. The company's net worth Soared by an impressive increase of 27.58%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Euphoria Formulation's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
₹20,695,000.00
₹2,000,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 09 Jun 2010 | Others | ₹2.07 Cr | Open |
| 23 Feb 2006 | Vijaya Bank | ₹2.00 M | Satisfied |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Euphoria Formulation, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Euphoria Formulation, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Euphoria Formulation's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Euphoria Formulation Private Limited last Annual general meeting of members was held on 26 Sep 2025 as per latest MCA records. was completed.
Progress on Euphoria Formulation Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai. was documented.
The activity A charge with Others of Rs. 20.70 M registered on 09 Jun 2010 with Charge ID 10230991 was modified on 16 Jun 2020. was completed.
Progress on A charge registered on 23 Feb 2006 via Charge ID 90354693 with Vijaya Bank was fully satisfied on 01 Jul 2011. was documented.
Nikhil Jain was appointed as a Director was appointed as a Director on 21 Jun 2011 & has been associated with this company since 14 years 5 months . was recorded as a recent event.
A charge with Others amounted to Rs. 20.70 M with Charge ID 10230991 was registered on 09 Jun 2010. was recorded as a recent event.
The CIN of Euphoria Formulation Private Limited is U51397MH2005PTC154012.
Euphoria Formulation Private Limited is headquartered at 1/12,Varma Nagar, Old Nagardas Road, Andheri East,, Mumbai, Maharashtra, 400069.
Euphoria Formulation Private Limited was incorporated on 16 June 2005.
The current directors of Euphoria Formulation Private Limited are
The primary industry of Euphoria Formulation Private Limited is Trade.
Euphoria Formulation Private Limited is unlisted.
The authorized capital of Euphoria Formulation Private Limited is ₹2.00 M, and the paid-up capital is ₹0.50 M.
The compliance status of Euphoria Formulation Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX